DNA repair enzyme uracil DNA glycosylase is specifically incorporated into human immunodeficiency virus type 1 viral particles through a Vpr- independent mechanism

Journal of Virology

Volumn 73, Issue 2, 1999, Pages 1682-1688

  Willetts, Karen E ^a   Rey, Françoise ^a   Agostini, Isabelle ^a   Navarro, Jean Marc ^a   Baudat, Yves ^a   Vigne, Robert ^a   Sire, Joséphine ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INTEGRASE; URACIL DNA GLYCOSYLTRANSFERASE; VPR PROTEIN;

ARTICLE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; VIRION; VIRUS PARTICLE;

EID: 0032902885     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.2.1682-1688.1999     Document Type: Article

References (39)

1. Agostini, I., J. M. Navarro, F. Rey, M. Boubamdan, B. Spire, R. Vigne, and J. Sire. 1996. The human immunodeficiency virus type 1 Vpr transactivator: cooperation with promoter-hound activator domains and binding to TFIIB. J. Mol. Biol. 261:599-606.
2. Ayyavoo, V., A. Mahboubi, S. Mahalingam, K. Ramalingam, S. Kudchodkar, W. V. Williams, D. G. Green, and D. B. Weiner. 1997. HIV-1 Vpr suppresses immune activation and apoptosis through regulation of nuclear factor κB. Nat. Med. 3:1117-1123.
3. Bess, J. W., P. J. Powell, H. J. Issaq, L. J. Schumack, M. K. Krimes. L. E. Henderson, and L. O. Arthur. 1997. Microvesicles are a source of contaminating cellular proteins found in purified HIV-1 preparations. Virology 230:134-144.
4. Bouhamdan, M., S. Benichou, F. Rey, J. M. Navarro, I. Agoslini, B. Spire, J. Camonis, G. Slupphaug, R. Vigne, R. Benarous, and J. Sire. 1996. Human immunodeficiency virus type 1 Vpr protein binds to the uracil DNA glycosylase DNA repair enzyme. J. Virol. 70:697-704.
5. Bouhamdan, M., Y. Xue, Y. Baudat, B. Hu, J. Sire, R. Pomerantz, and L. Duan. 1998. Diversity of HIV-1 Vpr interactions involves usage of the WxxF motif of host cell proteins. J. Biol. Chem. 273:8009-8016.
6. Gag precursor. J. Virol. 71:9358-9365.
7. Bukrinsky, M., S. Haggerty, M. Dempsey, N. Sharova, A. Adzhubel, L. Spitz, P. Lewis, D. Goldfarb, M. Emerman, and M. Stevenson. 1993 A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells. Nature 365:666-669.
8. Cohen, E. A., E. F. Terwilliger, Y. Jalinoos, J. Proulx, J. G. Sodroski, and W. A. Haseltine. 1990. Identification of HIV-1 Vpr product and function. J. Acquired Immune Defic. Syndr. 3:11-18.
9. Conti, L., G. Rainaldi, P. Matarrese, B. Varano, R. Rivabene, S. Columba, A. Sato, F. Bellardelli, W. Malorni, and S. Gessani. 1998. The HIV-1 Vpr protein acts as a negative regulator of apoptosis in a human lymphoblastoid T cell line: possible implications for the pathogenesis of AIDS. J. Exp. Med. 187:403-413.
10. De Rocquigny, H., P. Petitjean, V. Tanchou, D. Decimo, L. Drouot, T. Delaunay, J. L. Darlix, and B. P. Rocques. 1997. The zinc lingers of HIV nucleocapsid protein NCp7 direct interactions with the viral regulatory protein Vpr. J. Biol. Chem. 272:30753-30759.
11. Elder, J. H., D. L. Lerner, C. S. Hasseikus-Light, D. J. Fontenot, E. Hunter, P. A. Luciw, R. C. Montelaro, and T. R. Phillips. 1992. Distinct subsets of retroviruses encode dUTPase. J. Virol. 66:1791-1794.
12. Farnet, C. M., and W. A. Haseltine. 1991. Determination of viral proteins present in the human immunodeficiency virus type 1 preintegration complex. J. Virol. 55:1910-1915.
13. Franke, E. K., H. En Hui Yuan, and J. Luban. 1994. Specific incorporation of cyclophilin A into HIV-1 virions. Nature 372:359-362.
14. Gallay, P., T. Hope, D. Chin, and D. Trono. 1997. HIV-1 infection of non-dividing cells through the recognition of integrase by the importin/; karyopherin pathway. Proc. Natl. Acad. Sci. USA 94:9825-9830.
15. Gluschankof, P., I. Mondor, H. R. Gelderblom, and Q. Sattentau. 1997. Cell membrane vesicles arc a major contaminant of gradient-enriched human immunodeficiency virus type 1 preparations. Virology 230:125-133.
16. Heinzenberg, N. K., M. I. Bukrinsky, S. A. Haggerty, A. M. Ragland, V. Kewalramani, M.-A. Lee, H. E. Gendelman, L. Ratner, M. Stevenson, and M. Emerman. 1994. The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc. Natl. Acad. Sci. USA 91:7311-7315.
17. 2 + M phase of the cell cycle. J. Virol. 69:6304-6313.
18. Gag domain of human immunodeficiency virus type 1 is sufficient for the incorporation of Vpr into heterologous viral particles. J. Virol. 69:2759-2764.
19. Gag precursor for incorporation of the Vpr product in human immunodeficiency virus type 1 viral particles. J. Virol. 68:1926-1934.
20. Layne, S. P., M. J. Merges, M. Dembo, J. L. Sponge, S. R. Conley, J. P. Moore, J. L. Raina, H. Renz, H. R. Genderblom, and P. L. Nara. 1992. Factors underlying spontaneous inactivation and susceptibility to neutralisation of human immunodeficiency virus. Virology 189:695-714.
21. Lu, Y. L., P. Spearman, and L. Ratner. 1993. Human immunodeficiency virus type 1 viral protein R localization in infected cells and virions. J. Virol. 67:6542-6550.
22. Mahalingam, S., V. Ayyavoo, M. Patel, T. Kieber-Emmons, and D. B. Weiner. 1997. Nuclear import, virion incorporation, and cell cycle arrest/ differentiation are mediated by distinct functional domains of human immunodeficiency virus type 1 Vpr. J. Virol. 71:6339-6347.
23. Nagelhus, T. A., T. Haug, K. K. Singh, K. F. Keshav, F. Skorpen, M. Otterlei, S. Bhareti, T. Lindmo, S. Benichou, R. Benarous, and H. E. Krokan. 1997. A sequence in the N-terminal region of human uracil-DNA glycosylase with homology to XPA interacts with the C-terminal part of the 34-kDa subunit of replication protein. A. J. Biol. Chem. 272:6561-6566.
24. Neidermann, P., and J. Jiricny. 1993. The purification of a mismatch-specific thymine-DNA glycosylase from HeLa cells. J. Biol. Chem. 268:21218-21224.
25. Olsen, L. C., R. Aasland, C. U. Wittwer, H. E. Krokan, and D. E. Heiland. 1989. Molecular cloning of human uracil-DNA glycosylase, a highly conserved DNA repair enzyme. EMBO J. 8:3121-3125.
26. Gag protein of Moloney murine leukemia virus. J. Virol. 72:2962-2968.
27. Paxton, W., R. I. Connor, and N. L. Landau. 1993. Incorporation of Vpr into human immunodeficiency virus type 1 virions: requirement for the p6 region of Gag and mutational analysis. J. Virol. 67:7229-7237.
28. Popov, S., M. Rexach, G. Zybarth, N. Reiling, M. A. Lee, L. Ratner, C. M. Lane, M. S. Moore, G. Blobel, and M. Bukrinsky. 1998. Viral protein R regulates nuclear import of the HIV-1 preintegration complex. EMBO J. 17:909-917.
29. Rey, F., M. Bouhamdan, J. M. Navarro, I. Agostini, K. Willetts, M. Bouyac, C. Tamalet, B. Spire, R. Vigne, and J. Sire. 1998. A role for HIV-1 Vpr during infection of peripheral blood mononuclear cells. J. Gen. Virol. 79: 1083-1087.
30. Rogel, M. E., L. I. Wu, and M. Emerman. 1995. The human immunodeficiency virus type 1 vpr gene prevents cell proliferation during chronic infection. J. Virol. 69:882-888.
31. Shapiro, R. 1981. In E. Seeberg and K. Kleppe (ed.). Chromosome damage and repair, p. 13-18. Plenum, New York, N.Y.
32. Slupphaug, G., F. H. Markussen, L. C. Olsen, R. Aaslande, N. Aarsaether, O. Bakke, H. E. Krokan, and D. E. Heiland. 1993. Nuclear and mitochondrial forms of human uracil-DNA glycosylase are encoded by the ame gene. Nucleic Acids Res. 11:2579-2584.
33. Slupphaug, G., I. Effedal, B. Kavli, S. Bharati, N. M. Helle, T. Haug, D. W. Levine, and H. E. Krokan. 1995. Properties of a recombinant human uracil-DNA glycosylase from the UNG gene and evidence that UDG encodes the major uracil-DNA glycosylase. Biochemistry 34:128-138.
34. Stewart, S. A., B. Poon, J. B. M. Jowett, and I. S. Y. Chen. 1997. Human immunodeficiency virus type 1 Vpr induces apoptosis following cell cycle arrest. J. Virol. 71:5576-5592.
35. Sutter, G., M. Ohlmann, and V. Erffe. 1995. Non-replicating vaccinia vector efficiently expresses T7 RNA polymerase. FEBS Lett. 371:9-12.
36. Turelli, P., F. Guiguen, J.-F. Mornex, R. Vigne, and G. Querat. 1997. dUTPase-minus caprine arthritis-encephalitis virus is attenuated for pathogenesis and accumulates G-to-A substitutions. J. Virol. 71:4522-4530.
37. Yao, X. J., R. A. Subramanian, N. Rougeau, F. Boisvert, D. Bergeron, and E. A. Cohen. 1995. Mutagenic analysis of human immunodeficiency virus type 1 Vpr: role of a predicted N-terminal alpha-helical structure in Vpr nuclear localization and virion incorporation. J. Virol. 69:7032-7044.
38. Wang, L., S. Mukherjee, F. Jia, O. Narayan, and L. J. Zhao. 1995. Interaction of virion protein Vpr of human immunodeficiency virus type 1 with cellular transcription factor Sp1 and trans-activation of viral long terminal repeat. J. Biol. Chem. 270:25564-25569.
39. Wyatt, U S., B. Moss, and S. Rozenblatt. 1995. Replication-deficient vaccinia virus encoding bacteriophage T7 RNA polymerase for transient gene expression in mammalian cells. Virology 210:202-205.